Financing or buyout / partnershipThere are a lot of people who are convinced a financing is on its way. That is the only logical explanation why we have a .33 sp. Once we have either a financing or partnership happen, our SP will start to trade using a discounted algorithm based on probability of fda success. Until then, this trading is an indication of absolutely nothing. Get on with the financing if you are going this route or partner up. At least this way we can get a realistic valuation based in potential fda approval. If our 500mm peak sales valuation is 2 x revenue, then it should be, with a 50% probability of fda success ( personally think it is closer to 80% as SuJan stated in their seeking alpha article) then the market cap should reflect this, giving us a market cap of 2.50 USD per share. So i expect us to Make it to close to 3 per share before fda decision time is nigh, provided cash is removed from their equation. Bring on the cash berendt. GLTA